Department of Internal Medicine IV, Section of Nephrology, Klinikum Wels-Grieskirchen, Wels, Austria.
Medical Faculty, Johannes Kepler University, Linz, Austria.
Nat Rev Nephrol. 2021 May;17(5):291-293. doi: 10.1038/s41581-021-00406-6. Epub 2021 Feb 8.
Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.
患有肾脏疾病的患者应优先接种 COVID-19 疫苗,现有数据表明,复制缺陷型病毒载体疫苗和 mRNA 疫苗的使用是安全的。由于肾脏疾病患者的疫苗反应可能低于一般人群,因此应优先选择高效疫苗。